ArticleCancer letters2012

The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α.

Haiquan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.